SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-034121
Filing Date
2023-07-12
Accepted
2023-07-12 07:13:29
Documents
13
Period of Report
2023-07-06
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20055746_8k.htm   iXBRL 8-K 35949
2 EXHIBIT 99.1 brhc20055746_ex99-1.htm EX-99.1 8348
  Complete submission text file 0001140361-23-034121.txt   190441

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA avro-20230706.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20230706_lab.xml EX-101.LAB 23290
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20230706_pre.xml EX-101.PRE 16550
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc20055746_8k_htm.xml XML 4383
Mailing Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 6TH FLOOR CAMBRIDGE MA 02139 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 231083251
SIC: 2836 Biological Products, (No Diagnostic Substances)